A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Phase of Trial: Phase II/III
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Uproleselan-sodium (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 01 Feb 2019 Status changed from not yet recruiting to recruiting.
- 08 Oct 2018 Status changed from planning to not yet recruiting.
- 22 Aug 2018 New trial record